INS and Hyperglycemia: Our study adds by showing that metabolomic signatures associated with liability to type 2 diabetes resemble the signatures for fasting insulin, which implies that signals of liability to type 2 diabetes cannot be solely explained by hyperglycemia but is likely more related to the consequence of elevated insulin.